PARP inhibitors in BRCA1-/BRCA2-associated and triple-negative breast cancers

Future Oncol. 2010 Apr;6(4):485-6. doi: 10.2217/fon.10.27.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • BRCA1 Protein / genetics*
  • BRCA2 Protein / genetics*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / genetics*
  • Enzyme Inhibitors / therapeutic use*
  • Female
  • Humans
  • Poly(ADP-ribose) Polymerase Inhibitors*

Substances

  • Antineoplastic Agents
  • BRCA1 Protein
  • BRCA2 Protein
  • Enzyme Inhibitors
  • Poly(ADP-ribose) Polymerase Inhibitors